Current position: Home-Yong Liu >> Scientific Research >> Paper Publications

Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases

Release Time:2024-09-03  Hits:

Indexed by: Journal Papers

Document Code: 373195

Date of Publication: 2023-10-18

Journal: TOXICOLOGY IN VITRO

Volume: 92

ISSN: 0887-2333

Key Words: ADVANCED HEPATOCELLULAR-CARCINOMA; DYSFUNCTION; EFFICACY; GLUCURONIDATION; IN-VITRO; METABOLISM; PHARMACOKINETICS; PHASE-I; PREDICTION; SOLID TUMORS

Prev One:Higher risk of hepatotoxicity associated with cabozantinib in cancer patients

Next One:Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro
Recommended Ph.D.Supervisor Recommended MA Supervisor Institutional Repository Personal Page

Address: No.2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, P.R.C., 116024

Click:Times MOBILE Version
The Founding Time : ..
The Last Update Time : ..

Mobile phone sweep